Migrasaf Tablet
By Migrasaf
Rx
10 Tablet in a Strip

Composition
Domperidone(10mg) + Flunarizine(5mg) + Paracetamol(325mg)

Manufacturer - SAF Fermion Ltd
Millennium City Information Technology Park, Tower-II, Plot No. 62, Block-DN, Sector V, 8th floor, Salt Lake, Kolkata: 700 091

Expires on or after
October, 2025

liver
When using Migrasaf Tablet, it is important to exercise caution if you have any existing liver disease. In such cases, it may be necessary to adjust the dosage of the tablet. It is crucial to consult your doctor before starting or continuing the use of Migrasaf Tablet if you have any liver issues. It is advised not to use this tablet if you have severe liver disease or if your liver disease is actively ongoing. Always seek guidance from your healthcare provider to ensure the safe use of Migrasaf Tablet in relation to liver conditions.

kidney
Limited data suggests Migrasaf Tablet is likely safe for patients with kidney disease. Consult your doctor as dose adjustment may not be necessary.

alcohol
Consult your doctor when consuming alcohol with Migrasaf Tablet.

driving
When using Migrasaf Tablet, be cautious as it may reduce alertness, affect vision, and cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Migrasaf Tablet may not be safe to use during pregnancy. Animal studies suggest potential harm to the developing baby. Your doctor will assess the benefits versus risks before recommending this medication. Always consult your doctor before using Migrasaf Tablet during pregnancy.

breastfeeding
It is better to consult your doctor before using Migrasaf Tablet during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹100
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025